Key result
Dogs with cardiac diseases exhibited lower hemoglobin levels and marked alterations in other hematological and biochemical parameters compared to healthy controls.
Why the study?
What are the clinicopathological changes in dogs with cardiac diseases compared to healthy dogs?
Case-Control (n=37)
No
What are the clinicopathological changes in dogs with cardiac diseases compared to healthy dogs?
Dogs with cardiac diseases exhibit significant hematological and biochemical alterations, including anemia, leukocytosis, and elevated liver and kidney enzymes, likely reflecting secondary organ involvement.
Answers are grounded in this paper and cite their sources.
Hematological monitoring may warrant consideration in canine cardiac cases but should not yet change practice; leaves open need for prospective studies on prognostic utility.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Amaravathi et al. (2020) conducted a case-control in Cardiac diseases (n=37). Cardiac diseases vs. Apparently healthy dogs was evaluated on Hemoglobin (gm%) (p=<0.01). Dogs with cardiac diseases exhibited lower hemoglobin levels and marked alterations in other hematological and biochemical parameters compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: